Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease

The incidence of inflammatory bowel diseases (IBD) is rising worldwide. The therapeutic options for IBD are expanding, and the number of drugs with new targets will rapidly increase in coming years. A rapid step-up approach with close monitoring of intestinal inflammation is extensively used. The fe...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran-Minh, My-Linh, Sousa, Paula, Maillet, Marianne, Allez, Matthieu, Gornet, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424291/
https://www.ncbi.nlm.nih.gov/pubmed/28539989
http://dx.doi.org/10.4254/wjh.v9.i13.613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424291/
https://www.ncbi.nlm.nih.gov/pubmed/28539989
http://dx.doi.org/10.4254/wjh.v9.i13.613

Ejemplares similares